Updated Jul 16, 2026
George Jeffrey P. has filed 2 SEC Form 4 filings across 2 companies in the last 90 days — buying. Lifetime open-market purchases: $50K.
George Jeffrey P. is a director at LENZ Therapeutics, Inc. His specific contributions and background details are not widely documented in publicly available sources, indicating he may not be a widely recognized figure in the corporate world.
| Role | Director |
|---|---|
| Notability | 10/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-05-08 | AMRX | Amneal Pharmaceuticals, Inc. | M — Option exercise | 34.8K | — | |
| 2026-03-30 | LENZ | LENZ Therapeutics, Inc. | P — Open-market purchase | 5.6K | $8.92 | $50K |
George Jeffrey P. is a director at LENZ Therapeutics, Inc. His specific contributions and background details are not widely documented in publicly available sources, indicating he may not be a widely recognized figure in the corporate world.…
2 primary Form 4 filings in the last 90 days, covering 2 companies.
Recorded transactions: 1 open-market purchases ($50K) and 0 open-market sales () across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live George Jeffrey P. profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.